- Home
- INCR vs ACOG Comparison
INCR vs ACOG Comparison
Compare INCR & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INCR
- ACOG
- Stock Information
- Founded
- INCR 1994
- ACOG 2000
- Country
- INCR Israel
- ACOG Canada
- Employees
- INCR N/A
- ACOG N/A
- Industry
- INCR Biotechnology: Pharmaceutical Preparations
- ACOG
- Sector
- INCR Health Care
- ACOG
- Exchange
- INCR Nasdaq
- ACOG Nasdaq
- Market Cap
- INCR 84.5M
- ACOG 80.3M
- IPO Year
- INCR N/A
- ACOG N/A
- Fundamental
- Price
- INCR $1.55
- ACOG $10.80
- Analyst Decision
- INCR
- ACOG Strong Buy
- Analyst Count
- INCR 0
- ACOG 1
- Target Price
- INCR N/A
- ACOG $20.00
- AVG Volume (30 Days)
- INCR 24.5K
- ACOG 67.4K
- Earning Date
- INCR 08-15-2025
- ACOG 08-14-2025
- Dividend Yield
- INCR N/A
- ACOG N/A
- EPS Growth
- INCR N/A
- ACOG N/A
- EPS
- INCR N/A
- ACOG N/A
- Revenue
- INCR $65,575,323.00
- ACOG $2,928,654.00
- Revenue This Year
- INCR $69.54
- ACOG N/A
- Revenue Next Year
- INCR $41.75
- ACOG N/A
- P/E Ratio
- INCR N/A
- ACOG N/A
- Revenue Growth
- INCR N/A
- ACOG N/A
- 52 Week Low
- INCR $1.17
- ACOG $3.75
- 52 Week High
- INCR $2.62
- ACOG $11.54
- Technical
- Relative Strength Index (RSI)
- INCR 60.11
- ACOG N/A
- Support Level
- INCR $1.48
- ACOG N/A
- Resistance Level
- INCR $1.56
- ACOG N/A
- Average True Range (ATR)
- INCR 0.06
- ACOG 0.00
- MACD
- INCR 0.01
- ACOG 0.00
- Stochastic Oscillator
- INCR 80.99
- ACOG 0.00
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.
About ACOG Alpha Cognition Inc. Common Stock
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.